| 0 |
MACULA THICKNESS MEASUREMENT |
1 |
0.2500 |
| 1 |
GASTRODUODENITIS HAEMORRHAGIC |
1 |
0.0312 |
| 2 |
RETINAL DEPOSITS |
5 |
0.0246 |
| 3 |
MACULAR THICKENING |
2 |
0.0238 |
| 4 |
ENTEROCOLITIS INFECTIOUS |
13 |
0.0141 |
| 5 |
ACCESSORY SPLEEN |
1 |
0.0111 |
| 6 |
DYSCHROMATOPSIA |
5 |
0.0060 |
| 7 |
ADENOIDAL DISORDER |
1 |
0.0038 |
| 8 |
OVERGROWTH BACTERIAL |
1 |
0.0037 |
| 9 |
ADHESIVE TAPE USE |
1 |
0.0026 |
| 10 |
DIVORCED |
1 |
0.0023 |
| 11 |
HOMELESS |
1 |
0.0022 |
| 12 |
BANKRUPTCY |
1 |
0.0022 |
| 13 |
TYPE V HYPERLIPIDAEMIA |
1 |
0.0021 |
| 14 |
PULMONARY FUNCTION TEST ABNORMAL |
3 |
0.0019 |
| 15 |
NERVE ROOT COMPRESSION |
1 |
0.0017 |
| 16 |
STAPHYLOCOCCAL ABSCESS |
1 |
0.0016 |
| 17 |
CENTRAL OBESITY |
1 |
0.0014 |
| 18 |
DELUSIONAL DISORDER, UNSPECIFIED TYPE |
1 |
0.0013 |
| 19 |
DISTURBANCE IN SEXUAL AROUSAL |
1 |
0.0011 |
| 20 |
METASTASES TO ADRENALS |
1 |
0.0011 |
| 21 |
PARTNER STRESS |
1 |
0.0010 |
| 22 |
MUCOSAL ULCERATION |
1 |
0.0010 |
| 23 |
PLEURAL FIBROSIS |
1 |
0.0010 |
| 24 |
MAGNETIC RESONANCE IMAGING ABNORMAL |
1 |
0.0008 |
| 25 |
LEFT ATRIAL DILATATION |
1 |
0.0008 |
| 26 |
RETINAL DISORDER |
2 |
0.0008 |
| 27 |
FOOD INTERACTION |
1 |
0.0006 |
| 28 |
CEREBRAL VENOUS THROMBOSIS |
1 |
0.0006 |
| 29 |
ESSENTIAL HYPERTENSION |
1 |
0.0005 |
| 30 |
IMPULSE-CONTROL DISORDER |
1 |
0.0005 |
| 31 |
TONGUE DISCOMFORT |
2 |
0.0005 |
| 32 |
URINARY HESITATION |
1 |
0.0004 |
| 33 |
URINE FLOW DECREASED |
1 |
0.0004 |
| 34 |
PARKINSON'S DISEASE |
1 |
0.0004 |
| 35 |
BLOOD PRESSURE DIASTOLIC ABNORMAL |
1 |
0.0004 |
| 36 |
CANCER PAIN |
1 |
0.0004 |
| 37 |
AORTIC ARTERIOSCLEROSIS |
1 |
0.0004 |
| 38 |
MEDICATION RESIDUE |
1 |
0.0004 |
| 39 |
GAMBLING DISORDER |
1 |
0.0004 |
| 40 |
HEART VALVE INCOMPETENCE |
1 |
0.0003 |
| 41 |
DIASTOLIC DYSFUNCTION |
1 |
0.0003 |
| 42 |
TESTICULAR PAIN |
1 |
0.0003 |
| 43 |
METASTASES TO SPINE |
1 |
0.0003 |
| 44 |
HEPATIC CYST |
1 |
0.0003 |
| 45 |
VIITH NERVE PARALYSIS |
1 |
0.0003 |
| 46 |
BONE LESION |
1 |
0.0003 |
| 47 |
TENDON INJURY |
1 |
0.0003 |
| 48 |
PHOTOPHOBIA |
5 |
0.0003 |
| 49 |
SNORING |
1 |
0.0003 |
| 50 |
OPTIC ISCHAEMIC NEUROPATHY |
1 |
0.0003 |
| 51 |
SUSPECTED COUNTERFEIT PRODUCT |
1 |
0.0003 |
| 52 |
INJECTION SITE EXTRAVASATION |
3 |
0.0002 |
| 53 |
INTERVERTEBRAL DISC DISORDER |
1 |
0.0002 |
| 54 |
RHINITIS ALLERGIC |
1 |
0.0002 |
| 55 |
NEPHROGENIC ANAEMIA |
1 |
0.0002 |
| 56 |
SPINAL COLUMN STENOSIS |
1 |
0.0002 |
| 57 |
PATHOLOGICAL FRACTURE |
1 |
0.0002 |
| 58 |
DYSLIPIDAEMIA |
1 |
0.0002 |
| 59 |
OBSTRUCTIVE AIRWAYS DISORDER |
2 |
0.0002 |
| 60 |
GLUCOSE TOLERANCE IMPAIRED |
1 |
0.0002 |
| 61 |
HEPATITIS CHOLESTATIC |
1 |
0.0002 |
| 62 |
INJECTION SITE VESICLES |
1 |
0.0002 |
| 63 |
NOCTURIA |
2 |
0.0002 |
| 64 |
MULTIPLE INJURIES |
1 |
0.0002 |
| 65 |
ERECTILE DYSFUNCTION |
4 |
0.0002 |
| 66 |
TRICUSPID VALVE INCOMPETENCE |
1 |
0.0001 |
| 67 |
OBSESSIVE-COMPULSIVE DISORDER |
1 |
0.0001 |
| 68 |
SLEEP APNOEA SYNDROME |
2 |
0.0001 |
| 69 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 70 |
ATELECTASIS |
1 |
0.0001 |
| 71 |
EMPHYSEMA |
1 |
0.0001 |
| 72 |
EPILEPSY |
3 |
0.0001 |
| 73 |
GLOSSODYNIA |
2 |
0.0001 |
| 74 |
OCULAR DISCOMFORT |
1 |
0.0001 |
| 75 |
MITRAL VALVE INCOMPETENCE |
1 |
0.0001 |
| 76 |
MYOCARDIAL ISCHAEMIA |
1 |
0.0001 |
| 77 |
MICTURITION URGENCY |
1 |
0.0001 |
| 78 |
EYELID OEDEMA |
1 |
0.0001 |
| 79 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
| 80 |
SINUS CONGESTION |
1 |
0.0001 |
| 81 |
PRODUCT TASTE ABNORMAL |
1 |
0.0001 |
| 82 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 83 |
IMPAIRED QUALITY OF LIFE |
1 |
0.0001 |
| 84 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 85 |
PULMONARY MASS |
1 |
0.0001 |
| 86 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 87 |
TOXIC EPIDERMAL NECROLYSIS |
1 |
0.0001 |
| 88 |
TENDONITIS |
1 |
0.0001 |
| 89 |
SWOLLEN TONGUE |
2 |
0.0001 |
| 90 |
DRUG-INDUCED LIVER INJURY |
2 |
0.0001 |
| 91 |
OBESITY |
1 |
0.0001 |
| 92 |
INTENTIONAL OVERDOSE |
4 |
0.0001 |
| 93 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 94 |
METASTASES TO BONE |
1 |
0.0001 |
| 95 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 96 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 97 |
METASTASES TO LIVER |
1 |
0.0001 |
| 98 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 99 |
BRADYCARDIA |
3 |
0.0001 |
| 100 |
CHOLESTASIS |
1 |
0.0001 |
| 101 |
DYSPHONIA |
3 |
0.0001 |
| 102 |
DISABILITY |
1 |
0.0001 |
| 103 |
VISUAL IMPAIRMENT |
6 |
0.0000 |
| 104 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 105 |
INTENTIONAL PRODUCT MISUSE |
4 |
0.0000 |
| 106 |
INTENTIONAL PRODUCT USE ISSUE |
4 |
0.0000 |
| 107 |
ANGIOEDEMA |
2 |
0.0000 |
| 108 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 109 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 110 |
PANCREATITIS ACUTE |
1 |
0.0000 |
| 111 |
ARRHYTHMIA |
2 |
0.0000 |
| 112 |
OSTEONECROSIS OF JAW |
1 |
0.0000 |
| 113 |
CELLULITIS |
2 |
0.0000 |
| 114 |
CHRONIC KIDNEY DISEASE |
3 |
0.0000 |
| 115 |
FLUSHING |
4 |
0.0000 |
| 116 |
HEPATITIS |
1 |
0.0000 |
| 117 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 118 |
MUCOSAL INFLAMMATION |
1 |
0.0000 |
| 119 |
ANHEDONIA |
1 |
0.0000 |
| 120 |
GASTROOESOPHAGEAL REFLUX DISEASE |
3 |
0.0000 |
| 121 |
PAIN IN JAW |
1 |
0.0000 |
| 122 |
ANGINA PECTORIS |
1 |
0.0000 |
| 123 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
| 124 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 125 |
BLOOD PRESSURE INCREASED |
5 |
0.0000 |
| 126 |
HIP FRACTURE |
1 |
0.0000 |
| 127 |
CHOLELITHIASIS |
1 |
0.0000 |
| 128 |
OSTEONECROSIS |
1 |
0.0000 |
| 129 |
EYE DISORDER |
1 |
0.0000 |
| 130 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 131 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 132 |
ILLNESS |
3 |
0.0000 |
| 133 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 134 |
SLEEP DISORDER |
2 |
0.0000 |
| 135 |
PRODUCT ADHESION ISSUE |
1 |
0.0000 |
| 136 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 137 |
OVERDOSE |
6 |
0.0000 |
| 138 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 139 |
AGITATION |
2 |
0.0000 |
| 140 |
DYSURIA |
1 |
0.0000 |
| 141 |
DYSARTHRIA |
1 |
0.0000 |
| 142 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 143 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 144 |
HYPOTENSION |
5 |
0.0000 |
| 145 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 146 |
MENTAL DISORDER |
1 |
0.0000 |
| 147 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 148 |
THROAT IRRITATION |
1 |
0.0000 |
| 149 |
VISION BLURRED |
3 |
0.0000 |
| 150 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 151 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 152 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 153 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 154 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 155 |
INFLAMMATION |
1 |
0.0000 |
| 156 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 157 |
PANCREATITIS |
1 |
0.0000 |
| 158 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 159 |
OEDEMA |
1 |
0.0000 |
| 160 |
ARTHROPATHY |
1 |
0.0000 |
| 161 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 162 |
HYPONATRAEMIA |
1 |
0.0000 |
| 163 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 164 |
BONE PAIN |
1 |
0.0000 |
| 165 |
WHEEZING |
1 |
0.0000 |
| 166 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 167 |
VERTIGO |
1 |
0.0000 |
| 168 |
FEELING HOT |
1 |
0.0000 |
| 169 |
HYPERSENSITIVITY |
3 |
0.0000 |
| 170 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 171 |
RHINORRHOEA |
1 |
0.0000 |
| 172 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 173 |
RENAL FAILURE |
2 |
0.0000 |
| 174 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 175 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 176 |
INJURY |
1 |
0.0000 |
| 177 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 178 |
BRONCHITIS |
1 |
0.0000 |
| 179 |
HOT FLUSH |
1 |
0.0000 |
| 180 |
DIABETES MELLITUS |
1 |
0.0000 |
| 181 |
PROSTATE CANCER |
1 |
0.0000 |
| 182 |
DRY MOUTH |
1 |
0.0000 |
| 183 |
DRUG ABUSE |
1 |
0.0000 |
| 184 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 185 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 186 |
DRUG WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 187 |
TACHYCARDIA |
1 |
0.0000 |
| 188 |
DEVICE ISSUE |
1 |
0.0000 |
| 189 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 190 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 191 |
ADVERSE EVENT |
1 |
0.0000 |
| 192 |
WEIGHT DECREASED |
3 |
0.0000 |
| 193 |
COUGH |
3 |
0.0000 |
| 194 |
DYSPHAGIA |
1 |
0.0000 |
| 195 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 196 |
MIGRAINE |
1 |
0.0000 |
| 197 |
DYSPEPSIA |
1 |
0.0000 |
| 198 |
SYNCOPE |
1 |
0.0000 |
| 199 |
SOMNOLENCE |
2 |
0.0000 |
| 200 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 201 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 202 |
SINUSITIS |
1 |
0.0000 |
| 203 |
HYPERTENSION |
2 |
0.0000 |
| 204 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 205 |
MALAISE |
4 |
0.0000 |
| 206 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 207 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 208 |
CHILLS |
1 |
0.0000 |
| 209 |
JOINT SWELLING |
1 |
0.0000 |
| 210 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 211 |
DIZZINESS |
4 |
0.0000 |
| 212 |
HYPERHIDROSIS |
1 |
0.0000 |
| 213 |
INSOMNIA |
2 |
0.0000 |
| 214 |
NEUTROPENIA |
1 |
0.0000 |
| 215 |
INFECTION |
1 |
0.0000 |
| 216 |
HYPOAESTHESIA |
1 |
0.0000 |
| 217 |
VOMITING |
3 |
0.0000 |
| 218 |
DRUG INTERACTION |
1 |
0.0000 |
| 219 |
DRUG DEPENDENCE |
1 |
0.0000 |
| 220 |
TREMOR |
1 |
0.0000 |
| 221 |
FALL |
2 |
0.0000 |
| 222 |
URTICARIA |
1 |
0.0000 |
| 223 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 224 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 225 |
MYALGIA |
1 |
0.0000 |
| 226 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 227 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 228 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 229 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 230 |
MUSCLE SPASMS |
1 |
0.0000 |
| 231 |
DYSPNOEA |
3 |
0.0000 |
| 232 |
ANAEMIA |
1 |
0.0000 |
| 233 |
PRURITUS |
2 |
0.0000 |
| 234 |
ALOPECIA |
1 |
0.0000 |
| 235 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 236 |
ERYTHEMA |
1 |
0.0000 |
| 237 |
WEIGHT INCREASED |
1 |
0.0000 |
| 238 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 239 |
BACK PAIN |
1 |
0.0000 |
| 240 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 241 |
FATIGUE |
3 |
0.0000 |
| 242 |
NAUSEA |
3 |
0.0000 |
| 243 |
ANXIETY |
1 |
0.0000 |
| 244 |
OFF LABEL USE |
3 |
0.0000 |
| 245 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 246 |
PAIN |
2 |
0.0000 |
| 247 |
DIARRHOEA |
2 |
0.0000 |
| 248 |
DRUG INEFFECTIVE |
3 |
0.0000 |
| 249 |
HEADACHE |
1 |
0.0000 |
| 250 |
DEATH |
1 |
0.0000 |